User profiles for I Wadlow
Imogen WadlowVerified email at unimelb.edu.au Cited by 131 |
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
…, BA Weir, JH Reiling, Q Sheng, PB Gupta, RC Wadlow… - Nature, 2009 - nature.com
The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are
aggressive and respond poorly to standard therapies. Although the identification of specific …
aggressive and respond poorly to standard therapies. Although the identification of specific …
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global …
…, T Seufferlein, N Tebbutt, JJ Vinholes, R Wadlow… - The Lancet, 2016 - thelancet.com
Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with
metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based …
metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based …
[HTML][HTML] Sex differences in medico-legal action against doctors: a systematic review and meta-analysis
Background The relationship between male sex and poor performance in doctors remains
unclear, with high profile studies showing conflicting results. Nevertheless, it is an important …
unclear, with high profile studies showing conflicting results. Nevertheless, it is an important …
[HTML][HTML] Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
An alternative to therapeutic targeting of oncogenes is to perform "synthetic lethality" screens
for genes that are essential only in the context of specific cancer-causing mutations. We …
for genes that are essential only in the context of specific cancer-causing mutations. We …
DNA microarrays in clinical cancer research
R Wadlow, S Ramaswamy - Current molecular medicine, 2005 - ingentaconnect.com
The recent sequencing of the human genome, coupled with advances in biotechnology, is
enabling the comprehensive molecular “profiling” of human tissues. In particular, DNA …
enabling the comprehensive molecular “profiling” of human tissues. In particular, DNA …
[HTML][HTML] A clean air plan for Sydney: An overview of the special issue on air quality in New South Wales
This paper presents a summary of the key findings of the special issue of Atmosphere on Air
Quality in New South Wales and discusses the implications of the work for policy makers …
Quality in New South Wales and discusses the implications of the work for policy makers …
[HTML][HTML] A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus
EC Ferber, M Kajita, A Wadlow, L Tobiansky… - Journal of Biological …, 2008 - ASBMB
Cell-cell contacts play a vital role in intracellular signaling, although the molecular mechanisms
of these signaling pathways are not fully understood. E-cadherin, an important mediator …
of these signaling pathways are not fully understood. E-cadherin, an important mediator …
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable …
…, S Shinagare, JY Wo, Y Boucher, RC Wadlow… - International Journal of …, 2014 - Elsevier
Purpose To evaluate the safety, efficacy and biomarkers of short-course proton beam
radiation and capecitabine, followed by pancreaticoduodenectomy in a phase 1/2 study in …
radiation and capecitabine, followed by pancreaticoduodenectomy in a phase 1/2 study in …
[HTML][HTML] Sox9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitors
…, I Hogan, S Kahler, H Hamilton, R Wadlow… - Nature …, 2021 - nature.com
Endothelial to mesenchymal transition (EndMT) is a leading cause of fibrosis and disease,
however its mechanism has yet to be elucidated. The endothelium possesses a profound …
however its mechanism has yet to be elucidated. The endothelium possesses a profound …
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
…, L Blaszkowsky, K Stuart, AX Zhu, J Allen, R Wadlow… - Cancer, 2013 - Wiley Online Library
BACKGROUND Both everolimus and temozolomide are associated with single‐agent activity
in patients with pancreatic neuroendocrine tumor (NET). A phase 1/2 study was performed …
in patients with pancreatic neuroendocrine tumor (NET). A phase 1/2 study was performed …